Howard Dorfman was Appointed as General Counsel at Ferring Pharmaceuticals.

Date of management change: June 11, 2011 

What Happened?

Parsippany, NJ-based Ferring Pharmaceuticals hired Howard Dorfman as GC.

 

About the Company

Ferring Pharmaceuticals Inc is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Ferring Pharmaceuticals Inc is based in Parsippany, NJ. You can find more information on Ferring Pharmaceuticals Inc at www.ferring.com

 

About the Person

Howard L. DORFMAN is Vice President and General Counsel at Ferring Pharmaceuticals, Inc. in Parsippany, NJ. Previously, he served as a Counsel in the Life Sciences group at Ropes & Gray LLP in New York, where he focused his practice on the pharmaceutical, medical device and biotech industries. Mr. Dorfman’s areas of expertise include FDA regulatory law, fraud and abuse, compliance programs, risk management processes, mergers and acquisitions, corporate governance and licensing and product liability. Prior to his time at Ropes & Gray, he was chief legal officer of the pharmaceutical division of Bayer Healthcare LLC, where he was responsible for legal oversight relating to the commercial, regulatory and compliance activities of the company’s pharmaceutical operations. Before joining Bayer, he worked at Bristol-Myers Squibb (BMS). First, as Counsel for litigation, he oversaw and directed nationwide mass tort litigation involving hormones, antibiotic (tetracycline) and medical device (silicone implant) products. Later, he became Counsel to the company’s U.S. Medicines Group, where he was responsible for the legal functions relating to the two largest prescription pharmaceuticals in the Bristol- Myers cardiovascular franchise. Mr. Dorfman has knowledge of the PhRMA Code, Office of the Inspector General (OIG) compliance and FDA-related legislation as well as federal and state fraud and abuse regulations and statutes. He established OIG compliance procedures at a major pharmaceutical company while counseling on Medicare, Medicaid and other healthcare reimbursement matters. Liaising with international stakeholders, he has developed FDA risk management plans and global drug labeling protocols in accordance with U.S. regulatory standards. He has lectured and published articles on a range of product liability and FDA regulatory issues. Mr. Dorfman received his BA with honors from Yeshiva University and his JD from Brooklyn Law School.  

 

Info Source

Company Announcement

 
 

Other IT executives who recently changed jobs as well: Sokol Amy, Rowell Steve, Fogo Georgina, Purvis Michael, Siverd Robert, Wall Howard, Sparco Joe, Klein Jeffery, Frazer-Schardt Erin, Mescher William, Winkler von Mohrenfels Yvonne

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.